FNDC5 and diabetes mellitus: Irisin has been widely reported to produce beneficial effects in diabetes; however, our results indicate that whereas low‐dose irisin alleviates cardiac fibrosis by inhibiting EndMT, high‐dose irisin enhances MMP expression thus likely MMP activity, which leads to abnormal synthesis and/or degradation of the ECM.